DBV Technologies | DBVT - صافي الدخل





صافي الدخل تغيير تاريخ
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amarin USD -1.22M 6.51M 2025-12
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
DBV Technologies USD -47.6M 2.77M 2026-03
Galectin Therapeutics USD -12.37M 880K 2024-06
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Incyte USD 585.6M 282.27M 2026-06
Insmed USD -13.24M 150.32M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
United Therapeutics USD 333M 58.1M 2026-06